HolderBook

ANBIO BIOTECHNOLOGY (NNNN)

Institutional ownership reported to the SEC as of Q2 2026, across 6 quarters.

12
Reporting holders
$985.2K
Reported value
0.0%
Held as options
+4
Holder change

Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.

Holders

FilerValueShares Their book Held Change
GEODE CAPITAL MANAGEMENT, LLC$366.6K26,7360.00%6q+3.8%+$13.3K
BANK OF AMERICA CORP /DE/$184.0K13,4190.00%newNEW
BNP PARIBAS FINANCIAL MARKETS$161.8K11,8000.00%5q+13.5%+$19.2K
MARSHALL WACE, LLP$157.7K11,5020.00%newNEW
MORGAN STANLEY$99.1K7,2310.00%5q-1.5%-$1.5K
UBS Group AG$11.4K8280.00%6q-86.9%-$75.6K
EverSource Wealth Advisors, LLC$2.6K1870.00%2q-29.7%-$1.1K
OSAIC HOLDINGS, INC.$1.1K770.00%newNEW
JPMORGAN CHASE & CO$718530.00%newNEW
Bare Financial Services, Inc$206150.00%2qHELD
Larson Financial Group LLC$6950.00%newNEW
Silver Grove Financial Group, Inc.$5540.00%newNEW

Quarter by quarter

Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.

QuarterHoldersValue SharesNewAdded TrimmedOptions
Q2 202612$985.2K71,8576230.0%
Q1 20268$1.3M50,3263400.0%
Q4 20255$894.3K29,7400120.0%
Q3 20259$2.3M62,2924310.0%
Q2 20255$936.7K29,5863100.0%
Q1 20253$495.5K66,4273000.0%